<DOC>
	<DOCNO>NCT01790386</DOCNO>
	<brief_summary>This study perform obtain data CORA system , new device currently test yet clear sale United State Food Drug Administration ( FDA ) . The purpose study validate CORA system compare result test standard care device call TEG system . Both system evaluate hemostasis , highly complex interactive process involve many protein cellular element , especially platelet , occur series interrelate phase , result either normal hemostasis tendency toward bleed clot complication .</brief_summary>
	<brief_title>Equivalency Study TEG CORA Hemostasis Systems</brief_title>
	<detailed_description>The study protocol specifies test use multiple reagent similar CORA TEG system . Tests run blood sample take patient undergo cardiovascular surgery cardiology procedure , two time throughout procedure . The test may perform three different pair time : Pre-Operation Post-Protamine , During Operation ( Post-Heparin ) ICU , Pre-Operation ICU . Patients select random determination pair time use , long number patient three group approximately . Following protocol define CLSI Standard EP09-A2 , equivalence two system demonstrate conclusion Standard Section 7 , Interpreting Results Comparing Internal Performance Criteria , find acceptable . The study protocol also specify test blood sample normal , health volunteer subject purpose determine CORA System Reference Ranges reagent use study . Reference range construct follow guideline specify CLSI Standard C28-A3c . All blood sample draw study use venous blood . Whole blood use study ; citrate heparinized sample use . All sample repeat twice ( run duplicate test ) . Quality Controls run instrument frequency specify manufacturer . Results obtain test use make treatment decision .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>18 year age ( group ) Age , gender , ace disease state document ( group ) In good health ( Reference Ranges group ) Subjects/patients age 18 ( group ) On medication affect hemostasis ( Reference Ranges group ) Having condition undergo treatment affect hemostasis ( Reference Ranges group )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>hemostasis</keyword>
	<keyword>thromboelastography</keyword>
	<keyword>coagulation</keyword>
	<keyword>TEG</keyword>
</DOC>